Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine
about
HIV-1 Tat protein enhances microtubule polymerizationSelective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replicationHomonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal proteinHIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cellsTat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replicationMultiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infectionRoles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactionsHIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier?Multi-low-dose mucosal simian immunodeficiency virus SIVmac239 challenge of cynomolgus macaques immunized with "hyperattenuated" SIV constructs.Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designInduction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.Viral exploitation and subversion of the immune system through chemokine mimicry.A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine.Novel biopanning strategy to identify epitopes associated with vaccine protection.Characterization of Tat antibody responses in Chinese individuals infected with HIV-1.Tat-neutralizing antibodies in vaccinated macaques.Human retroviruses after 20 years: a perspective from the past and prospects for their future control.Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism.Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein.Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV diseaseHomonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variantGeneration and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigenWhat does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription.Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.Identification of a novel sodium-coupled oligopeptide transporter (SOPT2) in mouse and human retinal pigment epithelial cells.Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system.Tits and bits of HIV Tat protein.HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand.Mechanism for HIV-1 Tat insertion into the endosome membrane.Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein.Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells.Identification of a novel Na+- and Cl--coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 TatHIV-1 Tat is unconventionally secreted through the plasma membrane.
P2860
Q21093229-920B23CE-D99C-496B-B0A0-B2BEF5E795C3Q24673389-95E2AF1D-53BB-4E3E-95D0-8212CEA334BAQ24684750-0F154885-4CAD-44B7-8371-DE490B3545F4Q27637986-2EF2EA8F-8C12-48F4-99E3-D5A35632100AQ28144137-22E7A610-193D-49DB-A45A-521F7977931AQ28214887-1EE20F07-B7C2-4207-A449-5027C775D175Q28246872-17B385C0-1C7D-48AA-8208-A5FA76F5DD7DQ28286819-526ABBCA-9F58-4A91-B46B-493DAABE1530Q33346504-8CCB7DB7-27A2-4DCB-A743-C235D1ADA9ADQ33648905-213AF3DB-78EB-4E42-B47C-C5E0A28C6377Q33839136-24479837-DC61-4B51-A735-1CFE6F7A0C71Q33845527-306C1045-9A2D-4A07-95E8-A245109E369FQ33908773-42E24B58-1BD6-4022-AE4F-9F25DD644CA5Q33933260-2C10E762-4ABA-4D70-8620-A1DC798B2F13Q34098868-7AA415E4-9008-4B2C-A64D-175B21E8E27EQ34488930-247A08EA-D969-4E01-997B-19266291883DQ34579037-AB142788-E753-49F8-9346-564642BF55F6Q34658608-D12CB50D-98D0-4865-B519-E5079F900655Q34755910-393D7A3A-5BC7-4080-9E74-53FAEA0D8D8BQ34792498-6E69FE6A-3129-41DB-85F3-714A3C73311CQ35020357-BF708F3A-7C0E-40EC-976A-222B58B2F203Q35024694-8567240B-17BA-41CD-9E96-74D39005C698Q35114827-FF0C8E1C-17DE-4208-AC18-888D5C6D3A01Q35828692-5234F6C1-C45D-4E83-B4C5-BD510AC92F02Q36516063-36D43AD0-8709-4D6E-9950-1390C29F7945Q36917002-72AA66B0-B3C9-45C2-98C0-8D15DF042E82Q37010956-9ECD1F2A-7784-47AC-8BF4-910FB0C76E95Q37220038-A6B29AC6-DFF0-4E55-8AB5-6FAC952653FAQ37273867-B46E1B8F-E5A1-4ADE-A07A-A57A17A39332Q37348901-E907C49D-87F4-4BCB-9504-D4A0E3A423FEQ37680138-2C0E0D34-9ADA-4437-A8AD-D339E73D357AQ37800635-43E04E95-2BAD-4F88-8906-D2CDB15C1340Q37825906-01CFC49D-1AC6-4C39-BC51-026C6F6CFFBEQ38457134-D45B0630-E774-435A-9DE2-1E786FF2C56CQ39834242-96B6A01B-ED1A-4BF3-978A-0E8542B1AB07Q40056807-47DCCD5D-B72E-46F3-AE15-482FA493A1D9Q40273841-E15E8B73-450C-445E-A676-938796AF2B94Q40508633-8BC6D910-CD5A-48DA-B788-FFF64B868B8AQ41847542-B04A6D63-0857-42F3-AFB7-D230BA177609Q44433562-B739E4E4-BB68-43A3-895B-3430AF67CA44
P2860
Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Tat as one key to HIV-induced ...... portant component of a vaccine
@ast
Tat as one key to HIV-induced ...... portant component of a vaccine
@en
type
label
Tat as one key to HIV-induced ...... portant component of a vaccine
@ast
Tat as one key to HIV-induced ...... portant component of a vaccine
@en
prefLabel
Tat as one key to HIV-induced ...... portant component of a vaccine
@ast
Tat as one key to HIV-induced ...... portant component of a vaccine
@en
P2860
P356
P1476
Tat as one key to HIV-induced ...... portant component of a vaccine
@en
P2860
P304
P356
10.1073/PNAS.96.15.8324
P407
P50
P577
1999-07-01T00:00:00Z